Formulary Search
Search Results : Pain (Palliative care) (Morphine sulfate - Pain (Palliative care))
Show Icon and Status Keys
- Immediate release tablets
- Oral solution
- Oro-dispersible
- Subcutaneous infusion
- Subcutaneous injection (sc)
- Modified release capsules
- Modified release tablets
Prescribe modified-release preparations by brand - refer to local guidelines for preferred brands. Zomorph capsules (12-hourly) can be opened for administration in patients unable to swallow the capsules.
- Injection
- Capsules
- Oral solution
For patients unable to tolerate / poor response to morphine.
- Modified release tablets
For use in patients where morphine sulfate is not suitable / not tolerated.
Modified-release preparations to be prescribed by brand
- Injection
Primary Care prescribing on advice from palliative care specialist team
See separate listings for palliative care and use in anaesthesia.
- Buccal tablets
- Lozenges
- Sublingual tablets
Immediate release fentanyl preparations are only on formulary for breakthrough pain in patients receiving opioid therapy for cancer pain.
- Nasal spray
Immediate release fentanyl preparations are only on formulary for breakthrough pain in patients receiving opioid therapy for cancer pain.
- Oral solution
- Subcutaneous infusion
- Subcutaneous injection (sc)
Unlicensed product. Palliative care team only - severe neuropathic / complex pain. Under specialist supervision.
- Subcutaneous injection (sc)
Off label use.
- Inhalation
Palliative care teams. In-patient use only.
Nitrous oxide 50% and oxygen 50%
- Subcutaneous infusion
- Subcutaneous injection (sc)
To be used in intractable cancer pain only.
Off-label use.